Hemostemix Inc.
HEM.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.39% | 48.49% | 65.85% | 54.15% | 58.17% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -100.00% | -100.00% | -80.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.73% | -20.89% | -31.71% | -38.35% | 366.55% |
| Change in Net Operating Assets | 515.50% | 788.37% | 113.78% | 130.74% | 177.64% |
| Cash from Operations | 83.85% | 88.48% | 87.52% | 77.75% | 72.97% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -103.51% | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.78% | -87.61% | -75.59% | -56.28% | -56.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 80.00% | 72.53% | 61.43% | -106.00% |
| Cash from Financing | -98.72% | -88.23% | -90.01% | -77.28% | -82.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.19% | 89.87% | 66.16% | 162.45% | -223.88% |